Bayer HealthCare Pharmaceuticals Supports New Jersey Governor's School in the Sciences at Drew University
WAYNE, N.J., July 22 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals is pleased to announce it will support the New Jersey Governor's School in the Sciences (NJGSS) at Drew University this summer. This is the second year in a row that Bayer HealthCare Pharmaceuticals has sponsored the program, which is the longest running of the active Governor's schools.
The NJGSS offers courses in neuroscience, cell biology, physics, mathematics, anthropology and chemistry. Eighty-five of the state's top math and science students representing 18 of New Jersey's 21 counties will participate in the three week program, which runs from July 11-31.
"We challenge these outstanding high school juniors with an academic program that they usually would not experience until well into their college careers," said Dr. David Miyamoto, director of the NJGSS at Drew University. "Students work together in teams on highly experiential research projects that lead to the writing of scientific-style papers and oral presentations of the work at a scientific-style conference."
"As a company dedicated to science, we recognize the importance of unique programs like the NJGSS," said Sandra J. Oliver, vice president, public policy and government affairs at Bayer. Located in Wayne, the company's aim is to develop and manufacture products that will improve human health by diagnosing, preventing and treating diseases.
Additionally, Making Science Make Sense® (MSMS) is Bayer's company-wide initiative that advances science literacy through hands-on, inquiry-based science education, employee volunteerism and a public education campaign. Currently, 12 Bayer sites around the country operate local MSMS programs, which together represent a national volunteer corps of more than 1,000 employees.
"Bayer HealthCare's generous support of the New Jersey Governor's School in the Sciences will continue to expose high school students throughout the state to opportunities and future careers in the sciences," said Governor Chris Christie. "I want to thank Bayer for its contribution to this worthwhile program. It is the support of local companies like Bayer that is invaluable in helping promote scientific learning, problem solving skills and leadership training to students throughout the Garden State."
About Drew University -- Founded in 1867, Drew is a selective, independent, coeducational university with a total enrollment of more than 2,700 students in its College of Liberal Arts, Caspersen School of Graduate Studies and Theological School. Widely recognized for academic excellence and its tight-knit, diverse community, Drew is routinely listed among the nation's top colleges by The Princeton Review. Having won Rhodes, Fulbright, Truman, Goldwater, Marshall and National Science Foundation scholarships, Drew students are among the best in the nation. The university is one of three in New Jersey with a chapter of Phi Beta Kappa, the nation's most prestigious academic honor society.
About Bayer HealthCare Pharmaceuticals Inc. -- Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a division of Bayer AG. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the U.S., Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology and Oncology. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.
SOURCE Bayer HealthCare Pharmaceuticals
More by this Source
Bayer to Present Data Investigating Recently Approved Adempas® (riociguat) Tablets
Oct 28, 2013, 09:51 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.